NeoMET Study in Neoadjuvant Treatment of Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: pCR Rate|BCT Rate|Safety
Interventions: DRUG: Metformin|DRUG: Docetaxel|DRUG: Epirubicin|DRUG: cyclophosphomide
Sponsor: Shanghai Jiao Tong University School of Medicine